|
|
|
|
A more recent version of this article appeared on February 1, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on August 6, 2004
Accepted on November 10, 2004
Center for Cardiovascular Research, Department of Medicine, University of Rochester, Rochester, NY 14642
Monitoring Editor: Jean Schwarzbauer
Extracellular matrix remodeling occurs during development, tissue repair, and in a number of pathologies, including fibrotic disorders, hypertension, and atherosclerosis. Extracellular matrix remodeling involves the complex interplay between extracellular matrix synthesis, deposition, and degradation. Factors that control these processes are likely to play key roles in regulating physiological and pathological extracellular matrix remodeling. Our data show that fibronectin polymerization into the extracellular matrix regulates the deposition and stability of other extracellular matrix proteins, including collagen I and thrombospondin-1. In the absence of continual fibronectin polymerization, there is a loss of fibronectin matrix fibrils, and increased levels of fibronectin degradation. Fibronectin degradation occurs intracellularly following endocytosis, and can be inhibited by chloroquine, an inhibitor of lysosomal degradation, and by caveolae-disrupting agents. Down-regulation of caveolin-1 by RNAi inhibits loss of fibronectin matrix fibrils, fibronectin internalization, and fibronectin degradation; these processes can be restored by reexpression of caveolin-1. These data show that fibronectin matrix turnover occurs through a caveolin-1 dependent process. Caveolin-1 regulation of fibronectin matrix turnover is a novel mechanism regulating extracellular matrix remodeling.
This article has been cited by other articles:
![]() |
F. Shi and J. Sottile Caveolin-1-dependent {beta}1 integrin endocytosis is a critical regulator of fibronectin turnover J. Cell Sci., July 15, 2008; 121(14): 2360 - 2371. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Peng, B. Zhang, D. Wu, A. J. Ingram, B. Gao, and J. C. Krepinsky TGF{beta}-induced RhoA activation and fibronectin production in mesangial cells require caveolae Am J Physiol Renal Physiol, July 1, 2008; 295(1): F153 - F164. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Beer and L. Pedersen Matrix Fibronectin Binds Gammaretrovirus and Assists in Entry: New Light on Viral Infections J. Virol., August 1, 2007; 81(15): 8247 - 8257. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H.J. Heerkens, A. S. Izzard, and A. M. Heagerty Integrins, Vascular Remodeling, and Hypertension Hypertension, January 1, 2007; 49(1): 1 - 4. [Full Text] [PDF] |
||||
![]() |
A. Schroder, B. Schroder, B. Roppenser, S. Linder, B. Sinha, R. Fassler, and M. Aepfelbacher Staphylococcus aureus Fibronectin Binding Protein-A Induces Motile Attachment Sites and Complex Actin Remodeling in Living Endothelial Cells Mol. Biol. Cell, December 1, 2006; 17(12): 5198 - 5210. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ray, E. C. Osmundson, and H. Kiyokawa Constitutive and UV-induced Fibronectin Degradation Is a Ubiquitination-dependent Process Controlled by beta-TrCP J. Biol. Chem., August 11, 2006; 281(32): 23060 - 23065. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Monaghan-Benson and P. J. McKeown-Longo Urokinase-type Plasminogen Activator Receptor Regulates a Novel Pathway of Fibronectin Matrix Assembly Requiring Src-dependent Transactivation of Epidermal Growth Factor Receptor J. Biol. Chem., April 7, 2006; 281(14): 9450 - 9459. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B. Carson-Walter, J. Hampton, E. Shue, D. M. Geynisman, P. K. Pillai, R. Sathanoori, S. L. Madden, R. L. Hamilton, and K. A. Walter Plasmalemmal Vesicle Associated Protein-1 Is a Novel Marker Implicated in Brain Tumor Angiogenesis Clin. Cancer Res., November 1, 2005; 11(21): 7643 - 7650. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Tkachenko, J. M. Rhodes, and M. Simons Syndecans: New Kids on the Signaling Block Circ. Res., March 18, 2005; 96(5): 488 - 500. [Abstract] [Full Text] [PDF] |
||||